Global Blood Therapeutics, Inc. Financials

Market Capitalization $4.62 Billion as of Oct. 1, 2022

Valuations Metrics as of Jan. 3, 2026

Trailing PE	14.29
Forward PE	14.45
Price to Sales TTM	C$0.66
Price to Book MRQ	C$0.77
Enterprise to Revenue	0.66
Enterprise to EBITDA	161.91

Financial Reports as of Oct. 31, 2025

Financials

Fiscal Year Ends	2025-01-31
Most Recent Quarter	2025-10-31
Profit Margin	4.59%
Operating Margin	-5.79%
Return on Assets TTM	-0.78%
Return on Equity TTM	5.61%

Income Statement

Revenue TTM	C$627,105,984
Revenue per Share TTM	C$19.49
Quarterly Revenue Growth	1.10%
Gross Profit TTM	C$250,620,992
EBITDA	C$2,567,000
Net Income to Common TTM	C$28,803,000
Diluted EPS TTM	C$0.90
Quarterly Earnings Growth YoY	20.20%

Balance Sheet

Total Cash MRQ	C$7,450,000
Total Cash per Share MRQ	C$0.23
Total Debt MRQ	C$
Total Debt to Equity MRQ	2.44
Current Ratio MRQ	1.07
Book Value per Share MRQ	C$16.66

Cash Flow

Operating Cash Flow TTM	C$10,618,000
Levered Free Cash Flow TTM	C$15,303,000

GBT Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	31,889,900
Float Shares	9,889,696
Avg 10 Volume	1,230
Avg 30 Volume	None
Shares Short	2,590
Short Ratio	0.73
Short % of Shares	%
% Held by Insiders	68.30%
% Held by Institutions	12.63%

Stock Price Summary

Beta	-0.01
Fifty Two Week Low	C$11.18
Fifty Two Week High	C$16.84
Fifty Two Week Change	-4.98%
Day 50 MA	C$12.68
Day 200 MA	C$12.83

Dividends and Splits

Forward Annual Dividend Rate	C$0.36
Forward Annual Dividend Yield	2.80%
Trailing Annual Dividend Rate	C$0.36
Trailing Annual Dividend Yield	2.80%
Payout Ratio	40.00%
Dividend Date	2026-01-05
Ex Dividend Date	2025-12-19
Last Split Factor
Last Split Date	2010-04-01